Merck Animal Health has acquired a controlling stake in Vallée S.A.
Merck Animal Health has acquired a controlling stake in Vallée S.A.
Merck Animal Health, known as MSD outside the USA and Canada, is the global animal health business unit of Merck. Through its commitment to the Science of Healthier Animals™, Merck Animal Health offers veterinarians, farmers, pet owners and governments a wide range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets.
Vallée was founded in 1961 in Uberlândia, State of Minas Gerais, as a company dedicated to the production of vaccines for foot-and-mouth disease. Vallée is one of the largest animal health companies in Brazil, with a diversified product offering, including vaccines, antiparasiticides, supplements, therapeutic, reproduction and nutritional products for both production animals and pets.
One of Oaklins’ teams in Brazil acted as the sole financial advisor for Merck Animal Health in this transaction.
Talk to the deal team
Richard Rainer
Oaklins Olimpia Partners
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more